Free Trial

NovoCure (NVCR) SEC Filings & 10K Form

NovoCure logo
$17.75 -0.45 (-2.47%)
Closing price 04:00 PM Eastern
Extended Trading
$17.71 -0.04 (-0.23%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NovoCure SEC Filings

DateFilerForm TypeView
05/05/2025
3:17 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
6:01 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
7:00 PM
BlackRock, Inc. (Filed by)
NovoCure (Subject)
Form SCHEDULE 13G/A
04/22/2025
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
6:01 AM
NovoCure (Filer)
Form DEF 14A
04/21/2025
6:02 AM
NovoCure (Filer)
Form DEFA14A
04/01/2025
4:00 PM
NovoCure (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SCHEDULE 13G
03/06/2025
3:40 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:41 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:41 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:41 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:42 PM
Ben Arye Barak (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:42 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:48 PM
Brackmann Christoph (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:27 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4/A
03/03/2025
8:26 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4/A
03/03/2025
8:26 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4/A
03/03/2025
8:26 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 4/A
03/03/2025
8:26 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4/A
03/03/2025
8:26 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4/A
03/03/2025
4:31 PM
NovoCure (Subject)
Paravasthu Mukund (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:34 PM
Leonard Frank X (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:01 PM
NovoCure (Subject)
Weinberg Uri (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:43 PM
Cordova Ashley (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:50 PM
NovoCure (Subject)
Paravasthu Mukund (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:36 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
6:01 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:05 AM
NovoCure (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/15/2025
3:23 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:28 PM
NovoCure (Subject)
Paravasthu Mukund (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:27 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:00 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:05 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
5:21 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:16 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

08/06/2024
3:17 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
7:19 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:20 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:21 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:22 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:24 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:25 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:16 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:17 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:18 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
6:05 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
12:14 PM
NovoCure (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
NovoCure (Subject)
Form SC 13G/A
06/06/2024
5:37 PM
NovoCure (Issuer)
Ocean Allyson J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:13 PM
Madden Martin J. (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:55 PM
Hung David (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:42 PM
LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:42 PM
NovoCure (Issuer)
Scannell Timothy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:43 PM
NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:43 PM
NovoCure (Issuer)
Stafford Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:09 PM
HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVCR) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners